SECTOR CAPSULE: DIGESTIVE REMEDIES IN COLOMBIA
10 October 2023
KEY DATA FINDINGS
Retail value sales grow by 13% in current terms in 2023 to COP651 billion
Diarrhoeal remedies is the best performing category in 2023, with retail value sales rising by 15% in current terms
to COP43.6 billion
Abbott Laboratories de Colombia SA is the leading player in 2023, with a retail value share of 29%
Retail sales are set to grow at a current value CAGR of 6% (2023 constant value CAGR of 2%) over the forecast
period to COP853 billion
Market size Digestive Remedies
Retail Value RSP - COP billion - 2009-2028
651
Forecast
800
600
400
200
0
2009 2023 2028
Source: Passport by Euromonitor International
Sales Performance Digestive Remedies
%Y-O-Y Retail Value RSP-Growth 2009-2028
12.9%
Forecast
60%
40%
20%
0%
-20%
-40%
-60% 2009 2023 2028
Source: Passport by Euromonitor International
© Euromonitor International 2023 www.euromonitor.com
Powered by TCPDF (www.tcpdf.org)
Downloaded by co-ean01 from 45.32.171.230 at 2024-05-17 22:57:32 UTC. EMIS. Unauthorized Distribution Prohibited.
2023 DEVELOPMENTS
Digestive remedies has been amongst the most dynamic categories within OTC. With people back to their normal
routines, which include an increase in the frequency of eating out of the home, they have been more prone to suffer from
bloating, reflux, or gastritis, for example. This has been combined with mental health issues related to stress and anxiety
that usually affect the digestive system by increasing acidity, stomach pain or irritable bowel syndrome, amongst other
ailments. These have been amongst the various factors behind the good performance of digestive remedies in 2023.
Antacids, one of the largest categories, is anticipated to be amongst the most successful during the year.
In addition, since the pandemic, enjoying life has become more relevant for many people, leading them to party or
hang out with friends more often. This has been reflected in the strong performance of alcoholic drinks in the on-trade
channel, which has benefited brands like Bonfiest Lua Plus and Sal de Frutas Lua, which are well known in the country and
strongly linked to alleviating hangover symptoms.
Company Shares of Digestive Remedies
% Share (NBO) - Retail Value RSP - 2023
Tecnoquímicas SA 20.23%
Laboratorios Pisa SA de C... 12.51%
Reckitt Benckiser de Colo... 8.27%
Synthesis Ltda y Cía SCA,... 5.18%
Bayer de Colombia SA 4%
Megalabs Colombia SAS 3.67%
Sanofi-Aventis Pharma SA 3.32%
Others 14.22%
Increasing share Decreasing share No change
Source: Passport by Euromonitor International
NATIONAL BRAND OWNERS TABLE
Company Name (NBO) Brand (GBO)
Abbott Laboratories de Colombia
Pedialyte (Abbott Laboratories Inc)
SA
Bayer de Colombia SA Alka-Seltzer (Bayer AG), Alka-Seltzer Extreme (Bayer AG)
Bussie SA, Laboratorios Treda (Laboratorios Sanfer SA de CV)
Genomma Lab Colombia Ltda Genoprazol (Genomma Lab Internacional SAB de CV)
GlaxoSmithKline Colombia SA Leche de Magnesia Phillips (Aspen Pharmacare Holdings Ltd), Mareol (Haleon plc)
JGB SA, Laboratorios Citromel (JGB SA, Laboratorios)
Johnson & Johnson de Colombia SA Mylanta (Kenvue Inc)
Labinco SA Labinpina (Labinco SA)
Laboratorio de Farmacología
Labfarve Cidron (Laboratorio de Farmacología Vegetal SA)
Vegetal SA
Bisbacter (Abbott Laboratories Inc), Colaxin (Abbott Laboratories Inc), Finigax
Laboratorio Franco Colombiano
(Abbott Laboratories Inc), Gastrum (Abbott Laboratories Inc), Gastrum Plux (Abbott
Lafrancol SAS
Laboratories Inc)
Laboratorios Coaspharma Hidralitos (Laboratorios Coaspharma)
Laboratorios Ecar Ltda Pasedol (Laboratorios Ecar Ltda)
Laboratorios Natural Freshly Infabo
Gax Off (Laboratorios Natural Freshly Infabo Ltda)
Ltda
Laboratorios Pisa SA de CV Electrolit (Pisa Laboratorios SA)
Megalabs Colombia SAS Ciruelax (Megalabs SA)
© Euromonitor International 2023 www.euromonitor.com
Powered by TCPDF (www.tcpdf.org)
Downloaded by co-ean01 from 45.32.171.230 at 2024-05-17 22:57:32 UTC. EMIS. Unauthorized Distribution Prohibited.
Merck Sharp & Dohme Colombia
Ditopax (Bayer AG)
SAS
Fybogel Granulos (Reckitt Benckiser Group Plc (RB)), Gaviscon (Reckitt Benckiser
Reckitt Benckiser de Colombia SA
Group Plc (RB))
Sanofi-Aventis Pharma SA Buscapina (Sanofi), Dulcolax (Sanofi), Pepsamar (Eurofarma Laboratórios SA)
Synthesis Ltda y Cía SCA,
Smecta (Laboratoires Mayoly Spindler SA)
Laboratorios
Bonfiest Lua (Tecnoquímicas SA), Gastrofast Advance (Tecnoquímicas SA), Hidraplus
Tecnoquímicas SA (Tecnoquímicas SA), Magnesia MK (Tecnoquímicas SA), Pancreatina MK
(Tecnoquímicas SA), Sal de Frutas Lua (Tecnoquímicas SA)
Source: Passport by Euromonitor International
DEFINITIONS AND METHODOLOGY
DIGESTIVE REMEDIES
Includes remedies designed and marketed to treat gastrointestinal problems.
METHODOLOGY
This report is derived from Euromonitor International’s Passport information system. Industry research is carried out by a
global team of more than 600 in-country analysts and is based on a core set of research techniques:
National-level desk research, company research and analysis, store checking, trade interviewing with national
players and market analysis
International-level desk research, multinational company research and analysis, trade interviewing with
international players and market analysis
To purchase the full version of this briefing, please visit https://www.euromonitor.com
© Euromonitor International 2023 www.euromonitor.com
Powered by TCPDF (www.tcpdf.org)
Downloaded by co-ean01 from 45.32.171.230 at 2024-05-17 22:57:32 UTC. EMIS. Unauthorized Distribution Prohibited.
